|Institution||NIHR Liverpool Pancreas Biomedical Research Unit, UK|
After gaining a B.Sc. (Hons) in Pharmacology, at University College Dublin, Eithne undertook a cancer-based molecular biology PhD, at University College Dublin, spending one-year of her is Ph.D. research time at the University of Berne, Switzerland. She remained in Switzerland for a further six years where she was a postdoctoral fellow, firstly at the Swiss Institute for Cancer Research (ISREC), Lausanne and subsequently at the Institute of Microbiology, University of Lausanne.
In 1999 she was appointed to the University of Liverpool, where she heads her own research group with a focus on biomarker development for pancreatic cancer. Along with members of her group, she has published a number of scientific papers, review articles and book chapters on pancreatic cancer. She is on the Executive Committee of the NIHR Liverpool Pancreas Biomedical Research Unit (PBRU), the only pancreas Biomedical Research Unit in the UK, and is biomarker lead for the Unit. She actively participates in a number of European Union consortia and is co-leader of a workgroup of the COST Action BM1204 EU_Pancreas.